Market Place
Sourcing Support
All News #Library
Generics
Cancer Drug Makers Seek 50% Price Hike Amid Platinum Surge
06 Apr 2026 //
ECONOMICTIMES
Generic HIV Drug Rollout To Take A Hit On Trial Push
28 Nov 2025 //
ECONOMICTIMES
Axsome Therapeutics Settles Sunosi Patent Dispute with Hetero Lab
27 May 2025 //
GLOBENEWSWIRE
India-based Hetero`s Paxlovid generic gets WHO backing
28 Dec 2022 //
REUTERS
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
31 Oct 2022 //
ENDPTS
Hetero launches Generic Lapatinib in India
15 Jan 2019 //
BIOSPECTRUM
Velcade (Bortezomib): Millennium Pharmaceuticals vs Hetero Labs Limited
24 Nov 2018 //
PATENT LITIGATION
Jardiance (empagliflozin) : Boehringer Ingelheim vs. Annora Pharma
20 Nov 2018 //
PATENT LITIGATION
Pomalyst (Pomalidomide): Celgene vs. Hetero Drugs Ltd.
21 Sep 2018 //
PATENT LITIGATION
Linezolid : Symed Labs, Hetero USA vs. Amneal Pharmaceuticals
15 Sep 2018 //
PATENT LITIGATION
Linezolid : Symed Labs & Hetero USA v. Amneal Pharmaceuticals
06 Sep 2018 //
PATENT LITIGATION
Aptiom® (Eslicarbazepine Acetate) : Bial - Portela & CA S.A v. Hetero Labs
08 Mar 2018 //
PATENT LITIGATION
Trintellix (Vortioxetine): H. Lundbeck v. Hetero USA
30 Jan 2018 //
PATENT LITIGATION
Hetero receives DCGI`s approval to launch generic FDC drug ‘Darunavir + Ritonavir’
15 Nov 2017 //
PHARMABIZ
Livalo® (Pitavastatin Calcium): Kowa Company, Ltd. Et Al v.Hetero Drugs Limited
14 Jun 2017 //
PATENT LITIGATION
Hetero gets DCGI nod for generic chronic hepatitis C drug
05 May 2017 //
ECONOMIC TIMES
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Hetero Labs
05 Apr 2017 //
PATENT LITIGATION
Dr. Reddy`s plant problems may derail launch of generic Glivec
09 Feb 2017 //
FIERCE PHARMA
Straight announces launch of biosimilars rituximab (MABALL ™) in India
05 Aug 2015 //
PR NEWS WIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.